• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散性血管内凝血的分类:临床和动物模型。

Classifying types of disseminated intravascular coagulation: clinical and animal models.

机构信息

Department of Internal Medicine (III), Kanazawa University School of Medicine, Takaramachi 13-1, Kanazawa, Ishikawa, 920-8641 Japan.

出版信息

J Intensive Care. 2014 Mar 6;2(1):20. doi: 10.1186/2052-0492-2-20. eCollection 2014.

DOI:10.1186/2052-0492-2-20
PMID:25520834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4267600/
Abstract

Disseminated intravascular coagulation (DIC) has a common pathogenesis in terms of persistent widespread activation of coagulation in the presence of underlying disease, but the degree of fibrinolytic activation often differs by DIC type. DIC with suppressed fibrinolysis is a DIC type usually seen in sepsis. Coagulation activation is severe, but fibrinolytic activation is mild. DIC with enhanced fibrinolysis is a DIC type usually seen in acute promyelocytic leukemia (APL). Both coagulation activation and fibrinolytic activation are severe. DIC with balanced fibrinolysis is a DIC type usually seen in solid tumors, with an intermediate pathogenesis between the above two types. In animal DIC models, lipopolysaccharide (LPS)-induced models are similar to suppressed-fibrinolytic-type DIC, whereas tissue factor (TF)-induced models are similar to enhanced fibrinolytic/balanced fibrinolytic DIC. Appropriate diagnosis and treatment may also differ depending on the DIC type.

摘要

弥散性血管内凝血(DIC)在存在基础疾病的情况下,凝血持续广泛激活方面具有共同的发病机制,但纤溶激活的程度通常因 DIC 类型而异。伴有抑制性纤溶的 DIC 是一种通常见于脓毒症的 DIC 类型。凝血激活严重,但纤溶激活较轻。伴有增强纤溶的 DIC 是一种通常见于急性早幼粒细胞白血病(APL)的 DIC 类型。凝血激活和纤溶激活都很严重。伴有平衡纤溶的 DIC 是一种通常见于实体瘤的 DIC 类型,其发病机制介于上述两种类型之间。在动物 DIC 模型中,脂多糖(LPS)诱导的模型类似于抑制性纤溶型 DIC,而组织因子(TF)诱导的模型类似于增强性/平衡性纤溶 DIC。适当的诊断和治疗也可能因 DIC 类型而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/310dd8ff9225/40560_2014_29_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/050137d35860/40560_2014_29_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/f136f342e145/40560_2014_29_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/c5faecbd577e/40560_2014_29_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/310dd8ff9225/40560_2014_29_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/050137d35860/40560_2014_29_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/f136f342e145/40560_2014_29_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/c5faecbd577e/40560_2014_29_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7317/4267600/310dd8ff9225/40560_2014_29_Fig4_HTML.jpg

相似文献

1
Classifying types of disseminated intravascular coagulation: clinical and animal models.弥散性血管内凝血的分类:临床和动物模型。
J Intensive Care. 2014 Mar 6;2(1):20. doi: 10.1186/2052-0492-2-20. eCollection 2014.
2
[Classifying types of DIC: clinical features and animal models].[弥散性血管内凝血的类型分类:临床特征与动物模型]
Rinsho Ketsueki. 2016 Apr;57(4):397-404. doi: 10.11406/rinketsu.57.397.
3
Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.弥散性血管内凝血相关心搏骤停后综合征患者的凝血-纤溶变化——纤溶抑制和纤溶激活不足导致器官功能障碍。
Thromb Res. 2013 Jul;132(1):e64-9. doi: 10.1016/j.thromres.2013.05.010. Epub 2013 May 30.
4
Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers.使用分子标志物研究弥散性血管内凝血中凝血与纤溶之间的平衡
Blood Coagul Fibrinolysis. 1994 Oct;5(5):829-32. doi: 10.1097/00001721-199410000-00022.
5
The effects of emicizumab on in vitro coagulation and fibrinolysis parameters in patients with disseminated intravascular coagulation with and without addition of anti-FVIII antibody.emicizumab 对伴有和不伴有抗 FVIII 抗体的弥漫性血管内凝血患者体外凝血和纤溶参数的影响。
Haemophilia. 2024 May;30(3):836-844. doi: 10.1111/hae.14997. Epub 2024 Mar 24.
6
Clinical aspects of DIC--disseminated intravascular coagulation.弥散性血管内凝血(DIC)的临床特征
Pol J Pharmacol. 1996 Jan-Feb;48(1):73-5.
7
An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.尽管凝血被大量激活,但增强的纤维蛋白溶解可预防弥散性血管内凝血中多器官功能衰竭的发生。
Crit Care Med. 2001 Jun;29(6):1164-8. doi: 10.1097/00003246-200106000-00015.
8
Hemostatic function in hyperfibrinolytic disseminated intravascular coagulation.高纤溶状态下弥散性血管内凝血的止血功能
Pediatr Int. 2019 Sep;61(9):872-881. doi: 10.1111/ped.13919.
9
[Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].[初诊急性早幼粒细胞白血病合并弥散性血管内凝血的经验性治疗分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):315-22. doi: 10.7534/j.issn.1009-2137.2014.02.010.
10
Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.在大鼠的组织因子诱导型和脂多糖诱导型弥散性血管内凝血(DIC)模型中,弥散性血管内凝血的病理生理学进展速率不同。
Blood Coagul Fibrinolysis. 2003 Apr;14(3):221-8. doi: 10.1097/01.mbc.0000061290.28953.57.

引用本文的文献

1
Boundary Criterion Validation for Predicting Clinical DIC During Delivery in Fibrinogen-FDP Plane Using Severe Placental Abruption, and Characteristics of Clinical DIC Coagulation-Fibrinolytic Activation.利用严重胎盘早剥在纤维蛋白原 - FDP平面预测分娩期临床弥散性血管内凝血的界值标准验证及临床弥散性血管内凝血凝血 - 纤溶激活特征
J Clin Med. 2025 Jul 22;14(15):5179. doi: 10.3390/jcm14155179.
2
Concomitant use of sivelestat sodium hydrate and antithrombotic drugs worsens the treatment outcome of patients with acute respiratory distress syndrome and suppression of fibrinolysis: a single-center, retrospective study.水合西维来司他钠与抗血栓药物联合使用会恶化急性呼吸窘迫综合征患者的治疗结果并抑制纤维蛋白溶解:一项单中心回顾性研究。
Fujita Med J. 2025 Aug;11(3):129-134. doi: 10.20407/fmj.2024-026. Epub 2025 Apr 17.
3

本文引用的文献

1
Massive amounts of tissue factor induce fibrinogenolysis without tissue hypoperfusion in rats.大量组织因子在没有组织低灌注的情况下诱导纤维蛋白原降解。
Shock. 2013 Jun;39(6):514-9. doi: 10.1097/SHK.0b013e318293980d.
2
Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT/ACOTS).区分弥散性血管内凝血(DIC)伴纤维蛋白溶解表型与创伤性凝血病和创伤性休克急性凝血病(COT/ACOTS)。
J Thromb Haemost. 2013 May;11(5):826-35. doi: 10.1111/jth.12190.
3
The utility of a diagnostic scoring system for disseminated intravascular coagulation.
Decreased factor XIII activity and haptoglobin may be markers of enhanced-fibrinolytic-type disseminated intravascular coagulation status: Case report.因子 XIII 活性降低和触珠蛋白可能是增强型纤溶型弥散性血管内凝血状态的标志物:病例报告。
Medicine (Baltimore). 2025 Jul 25;104(30):e43123. doi: 10.1097/MD.0000000000043123.
4
Refractory Disseminated Intravascular Coagulation Caused by Endovascular Invasion of Squamous Cell Carcinoma of the Lung: A Case Report.肺鳞状细胞癌血管内侵袭导致的难治性弥散性血管内凝血:一例报告
Cureus. 2025 May 16;17(5):e84243. doi: 10.7759/cureus.84243. eCollection 2025 May.
5
Management of COVID-19 associated coagulopathy in critically ill patients and the risk of acquired von willebrand syndrome.危重症患者新冠病毒疾病相关凝血病的管理及获得性血管性血友病综合征的风险
Sci Rep. 2025 Jun 2;15(1):19321. doi: 10.1038/s41598-025-99786-z.
6
Thrombocytopenia in the intensive care unit: diagnosis and management.重症监护病房中的血小板减少症:诊断与管理
Ann Intensive Care. 2025 Feb 22;15(1):25. doi: 10.1186/s13613-025-01447-x.
7
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: significance of guidelines developed for each underlying disease.《2024年日本弥散性血管内凝血管理临床实践指南:针对每种基础疾病制定指南的意义》
Int J Hematol. 2025 May;121(5):586-591. doi: 10.1007/s12185-025-03928-y. Epub 2025 Feb 15.
8
Prevalence and clinical impact of disseminated intravascular coagulation in acute aortic dissection: a nationwide cohort study.急性主动脉夹层中弥散性血管内凝血的患病率及临床影响:一项全国性队列研究
Res Pract Thromb Haemost. 2024 Dec 16;9(1):102656. doi: 10.1016/j.rpth.2024.102656. eCollection 2025 Jan.
9
Fibrinolytic Changes in Critical Illnesses: Is Fibrinolysis Shutdown a Specific Concept?危重症中的纤溶变化:纤溶关闭是一个特定概念吗?
Juntendo Iji Zasshi. 2024 Dec 31;70(6):416-419. doi: 10.14789/ejmj.JMJ24-0035-P. eCollection 2024.
10
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 3: solid cancers and vascular abnormalities.《2024年日本弥散性血管内凝血管理临床实践指南》。第3部分:实体癌与血管异常
Int J Hematol. 2025 May;121(5):622-632. doi: 10.1007/s12185-024-03912-y. Epub 2025 Jan 10.
弥散性血管内凝血诊断评分系统的实用性。
Crit Care Clin. 2012 Jul;28(3):373-88, vi. doi: 10.1016/j.ccc.2012.04.004.
4
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.氨甲环酸对手术出血的影响:系统评价和累积荟萃分析。
BMJ. 2012 May 17;344:e3054. doi: 10.1136/bmj.e3054.
5
Crosstalk between inflammation and coagulation: the lessons of sepsis.炎症与凝血的相互作用:脓毒症的启示。
Curr Vasc Pharmacol. 2012 Sep;10(5):632-8. doi: 10.2174/157016112801784549.
6
The role of tissue factor in systemic inflammatory response syndrome.组织因子在全身炎症反应综合征中的作用。
Blood Coagul Fibrinolysis. 2011 Sep;22(6):451-6. doi: 10.1097/MBC.0b013e328346ef3f.
7
Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature.创伤、休克和弥散性血管内凝血:经典文献中的教训。
Ann Surg. 2011 Jul;254(1):10-9. doi: 10.1097/SLA.0b013e31821221b1.
8
Disseminated intravascular coagulation in hematologic malignancies.弥漫性血管内凝血在血液恶性肿瘤中的表现。
Semin Thromb Hemost. 2010 Jun;36(4):388-403. doi: 10.1055/s-0030-1254048. Epub 2010 Jul 7.
9
Microvascular thrombosis and multiple organ dysfunction syndrome.微血管血栓形成与多器官功能障碍综合征。
Crit Care Med. 2010 Feb;38(2 Suppl):S35-42. doi: 10.1097/CCM.0b013e3181c9e31d.
10
Expert consensus for the treatment of disseminated intravascular coagulation in Japan.日本弥散性血管内凝血治疗专家共识。
Thromb Res. 2010 Jan;125(1):6-11. doi: 10.1016/j.thromres.2009.08.017. Epub 2009 Sep 25.